FDA unpersuaded by P&G's answer to Crest Gum Care warning letter; threatens legal action.
This article was originally published in The Tan Sheet
Executive Summary
FDA UNPERSUADED BY P&G's RESPONSE TO CREST GUM CARE WARNING LETTER, the agency told the company in a Nov. 17 letter. Responding to an Oct. 18 letter from Procter & Gamble, FDA stated that its "position regarding the status of Crest Gum Care toothpaste is unchanged." FDA said the toothpaste "is subject to the risk of further legal action as noted in the warning letter" if P&G continues to market the product.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning